Cerus reported $53.23M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Atrion ATRI:US 33.38M 479K
Cerulean Pharma CERU:US $ 12.67M 3.51M
Cerus CERS:US $ 53.23M 1.06M
Cytori Therapeutics CYTX:US $ 3.5M 924K
Haemonetics HAE:US $ 215.39M 11.75M
Meridian Bioscience VIVO:US $ 67.72M 19.88M
Neogen NEOG:US $ 118.05M 11.49M
Nuvasive NUVA:US $ 277.47M 6.61M
Orasure Technologies OSUR:US $ 66.93M 11.12M
Quidel QDEL:US $ 227.9M 74.59M
Rockwell Medical RMTI:US $ 22.96M 0
Sientra SIEN:US 31.31M 2.05M
Staar Surgical STAA:US $ 50.52M 1.2M
Terumo 4543:JP Y 143297M 7814M